 |
|
|
| |
All Oral HCV Therapy is Safe and Effective in Patients with Decompensated Cirrhosis: Report from HCV-TARGET
|
| |
| |
Reported by Jules Levin
EASL 2015 April 22-26 Vienna Austria
K. Rajender Reddy, Joseph K. Lim, Alexander Kuo,
Adrian M. Di Bisceglie, Hugo E. Vargas, Joseph S. Galati, Giuseppe Morelli, Gregory T. Everson, Paul Kwo, Robert S. Brown, Mark S. Sulkowski, Lucy Akushevich, Thomas G. Stewart, Monika Vainorius, Joy A. Peter, David Nelson, Michael W. Fried, Michael P. Manns for the HCV-TARGET Study Group
|
| |
|
|
|
|
|
